Want to see JP:4918 full AI Analyst Report?
Top Page
Ivy Cosmetics Corporation
(4918)
Select Model
Select Model
Rating:73Outperform
Price Target:
¥335.00
▼(-1.18% Downside)
Action:Reiterated
Date:07/03/26
The score is driven primarily by improved financial health (restored profitability, strong margins, and sharply reduced leverage) and supportive valuation (moderate P/E and high dividend yield). Technicals are positive due to a strong uptrend versus moving averages, but an overbought RSI meaningfully tempers the overall rating.
Positive Factors
Profitability Recovery
The return to positive net margins after the 2023 loss, combined with consistently strong gross margins near 70%, indicates improved operating economics. This provides a stronger base for recurring profitability, although future results still depend on restoring revenue growth.
Negative Factors
Revenue Contraction
Recent revenue contraction signals weak top-line momentum and may limit operating leverage if fixed costs remain in place. Sustained sales pressure could make the restored margins harder to preserve and constrain the company’s ability to expand earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
The return to positive net margins after the 2023 loss, combined with consistently strong gross margins near 70%, indicates improved operating economics. This provides a stronger base for recurring profitability, although future results still depend on restoring revenue growth.
Read all positive factors
Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥1.70B
Dividend Yield4.97%
Average Volume (3M)15.29K
Price to Earnings (P/E)8.9
Beta (1Y)0.60
Revenue Growth-6.17%
EPS Growth-55.84%
CountryJP
Employees179
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-39.92
Shares Outstanding6,414,000
10 Day Avg. Volume19,010
30 Day Avg. Volume15,293
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.75
Price to Sales (P/S)0.75
P/FCF Ratio5.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ivy Cosmetics Corporation Business Overview & Revenue Model
Company Description
Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, ...
Ivy Cosmetics Corporation Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.64B | 2.93B | 2.71B | 2.94B | 3.53B |
| Gross Profit | 1.84B | 2.07B | 1.91B | 2.11B | 2.42B |
| EBITDA | 236.31M | 20.62M | 242.60M | -33.16M | 185.13M |
| Net Income | 164.53M | 43.01M | 160.31M | -384.61M | 40.38M |
Balance Sheet | |||||
| Total Assets | 3.64B | 3.57B | 3.57B | 3.85B | 4.49B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 577.94M | 208.73M | 247.67M | 129.38M |
| Total Debt | 278.01M | 211.34M | 451.69M | 1.05B | 1.18B |
| Total Liabilities | 1.00B | 1.10B | 1.33B | 1.87B | 2.22B |
| Stockholders Equity | 2.64B | 2.47B | 2.24B | 1.98B | 2.27B |
Cash Flow | |||||
| Free Cash Flow | 385.37M | 424.68M | 408.70M | 243.33M | -160.58M |
| Operating Cash Flow | 451.04M | 445.94M | 453.06M | 278.59M | -107.06M |
| Investing Cash Flow | -58.15M | -18.43M | 7.30M | -29.30M | 63.30M |
| Financing Cash Flow | 70.61M | -58.27M | -499.31M | -131.00M | 59.71M |
Ivy Cosmetics Corporation Technical Analysis
Negative
339.00
Price Trends
311.44
Negative
305.87
Negative
326.75
Negative
Market Momentum
-3.33
Positive
43.32
Neutral
27.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Negative. The current price of 339 is above the 20-day moving average (MA) of 306.35, above the 50-day MA of 311.44, and above the 200-day MA of 326.75, indicating a bearish trend. The MACD of -3.33 indicates Positive momentum. The RSI at 43.32 is Neutral, neither overbought nor oversold. The STOCH value of 27.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4918.
Ivy Cosmetics Corporation Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥6.53B | 9.60 | ― | 2.29% | 0.16% | 6.35% | |
73 Outperform | ¥1.70B | 8.86 | ― | ― | -6.17% | -55.84% | |
65 Neutral | ¥2.36B | 6.83 | ― | 2.70% | 3.05% | 184.11% | |
65 Neutral | ¥5.35B | 29.17 | ― | 1.68% | 3.17% | -27.27% | |
59 Neutral | ¥5.94B | 30.75 | ― | 1.62% | -2.17% | 402.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | ¥5.21B | 20.60 | ― | ― | -18.19% | -65.57% |
* General Sector Average
JP:4918
Ivy Cosmetics Corporation
302.00
3.30
1.10%
JP:4920
Nippon Shikizai, Inc.
1,114.00
77.19
7.44%
JP:4925
HABA Laboratories, Inc.
1,727.00
17.85
1.04%
JP:4926
C'BON COSMETICS Co., Ltd.
1,250.00
65.78
5.55%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
742.00
-11.78
-1.56%
JP:4934
Premier Anti-Aging Co., Ltd.
593.00
-300.00
-33.59%
Ivy Cosmetics Corporation Corporate Events
IVY Cosmetics Posts Strong Sales Rebound but Stays in the Red
Aug 5, 2026
IVY Cosmetics Corporation reported a 29.5% year-on-year increase in net sales to ¥295 million for the quarter ended June 2026, reversing the prior year’s sales decline but remaining loss-making, with an operating loss of ¥238 milli...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.